🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
This study seeks to understand the performance of MRI to characterize pancr...
Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-18
Trial ID
NCT05659147
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The purpose of this study is to identify novel biomarkers of kidney injury ...
Status
Completed
Location
University of Chicago
Start Date
2009-09-22
Trial ID
NCT00984035
Treatments Being Tested
The purpose of this study is to learn how people with BRCA1/2 mutations res...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2025-09-25
Trial ID
NCT07197723
Treatments Being Tested
Multiple myeloma (MM) is a malignancy of plasma cells engaging in monoclona...
Status
Unknown
Location
University Hospital Center of Guadeloupe
Start Date
2019-11-19
Trial ID
NCT04260490
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested
The purpose of this study is to learn how to use blood tests to better pred...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-02-01
Trial ID
NCT04791215
Treatments Being Tested
This is an interventional, prospective, single-center study designed to col...
Status
Not Yet Recruiting
Location
Institut Universitaire du Cancer Toulouse - Oncopole, Laboratoire d'oncogénétique
Start Date
2026-10-15
Trial ID
NCT07558343
Treatments Being Tested
Systemic sclerosis (SSc) is the most severe of the systemic autoimmune dise...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT04986514
Treatments Being Tested